4E3-24837-18470
5 vaccinations
7 coded responses
31 check-ins
6 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 221 / VA
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Dose 1 — Moderna
-
2021-01-14
Registered in v-safe
- 2021-01-14
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-23
- 2021-01-27
- 2021-02-03
- 2021-02-10
-
2021-02-11
Dose 2 — Moderna
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-27
- 2021-05-13
-
2021-08-12
Survey response — 6 months, dose 2MedDRA: Cough — Feeling: GoodFree text: Cough, non-productive, intermittent, 2 month duration. Afebrile. No other symptoms.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-21
Dose 3 — Moderna
-
2022-02-11
Survey response — 12 months, dose 2MedDRA: Rash, Rash pruritic — Feeling: GoodFree text: Rash rash scalp face neck arms legs and torso with moderate to severe itching. Duration about two weeks. Onset mid November 2021MedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Dose 4 — Moderna
- 2022-04-27
-
2022-05-02
Survey response — day 14, dose 4MedDRA: Pruritus, Rhinorrhoea — Feeling: GoodFree text: Itching of skin of torso. RhinorrheaMedDRA releases: 2024-11 · check-in free text available
-
2022-05-09
Survey response — day 21, dose 4MedDRA: Cough, Rhinorrhoea, Self-medication — Feeling: GoodFree text: Rhinorrhea and cough improved with high dose OTC oral antihistamine and rainstorm.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-16
- 2022-05-23
- 2022-05-30
-
2022-07-18
Survey response — 3 months, dose 4MedDRA: Rash, Rash pruritic — Feeling: FairFree text: Rash with itching on torsoMedDRA releases: 2024-11 · check-in free text available
-
2022-10-10
Dose 5 — Moderna
-
2022-10-20
Survey response — 6 months, dose 4MedDRA: Pruritus, Rash, Rash pruritic — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diffuse itchy skin rash on chest and abdomen has increasedMedDRA releases: 2024-11 · check-in free text available
-
2022-10-20
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-21
Call successfulDoes not wish to fill out VAERS report
-
2023-04-12
Survey response — 6 months, dose 5MedDRA: COVID-19, Pyrexia, Rhinorrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-12
Report sent to call center — 6 months, dose 5Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-04-13
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Moderna | |
| 2 | 2021-02-11 | Moderna | |
| 3 | 2021-10-21 | Moderna | No |
| 4 | 2022-04-18 | Moderna | No |
| 5 | 2022-10-10 | Moderna | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 1
Free text
Release 9 — 6 months, dose 2
Symptoms: Cough, non-productive, intermittent, 2 month duration. Afebrile. No other symptoms.
Release 11 — 12 months, dose 2
Symptoms: Rash rash scalp face neck arms legs and torso with moderate to severe itching. Duration about two weeks. Onset mid November 2021
Release 11 — day 14, dose 4
Symptoms: Itching of skin of torso. Rhinorrhea
Release 11 — day 21, dose 4
Symptoms: Rhinorrhea and cough improved with high dose OTC oral antihistamine and rainstorm.
Release 12 — 3 months, dose 4
Symptoms: Rash with itching on torso
Release 12 — 6 months, dose 4
Symptoms: Diffuse itchy skin rash on chest and abdomen has increased
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Pruritus | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rash pruritic | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release